Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | METAP2 | P50579 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | MPI | P34949 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31046570 | 1.00 | KDM4E (0.43) | KDM4ELMNAHSP90AA1HSP90AB1MAPK1 | |
| SCHEMBL440401 | 0.93 | KDM4E (0.41) | KDM4ELMNAHSP90AA1HSP90AB1MAPK1 | |
| SCHEMBL30866395 | 0.93 | KDM4E (0.50) | KDM4ELMNAHSP90AA1HSP90AB1MAPK1 | |
| SCHEMBL17973332 | 0.90 | LMNA (0.51) | KDM4ELMNAHSP90AA1HSP90AB1MAPK1 | |
| SCHEMBL17396322 | 0.88 | TOP2A (0.41) | KDM4ELMNAHSP90AA1HSP90AB1MAPK1 | |
| SCHEMBL23406925 | 0.87 | KDM4E (0.41) | KDM4ELMNAHSP90AA1HSP90AB1MAPK1 | |
| SCHEMBL22686770 | 0.87 | CCR1 (0.48) | KDM4ELMNAHSP90AA1ALDH1A1HPGD | |
| SCHEMBL31096890 | 0.87 | CCR1 (0.48) | KDM4ELMNAHSP90AA1ALDH1A1HPGD | |
| SCHEMBL23406889 | 0.86 | ADORA1 (0.44) | KDM4ELMNAALDH1A1HPGDL3MBTL1 | |
| SCHEMBL18092547 | 0.84 | KDM4E (0.43) | KDM4EHSP90AA1HSP90AB1MAPK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118271313-A | Organic compound with symmetrical structure, application of organic compound and perovskite solar cell | 北京绿人科技有限责任公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-115894494-B | Ligand, complex and application thereof in electrochemical reaction | 南方科技大学 | 2024-06-18 | — | — | CN | disclosed |
| WO-2024014934-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE AND DISPLAY DEVICE | 삼성에스디아이 주식회사 | 2024-01-18 | — | — | WO | disclosed |
| WO-2023153905-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE | 삼성에스디아이 주식회사 | 2023-08-17 | — | — | WO | disclosed |
| CN-115894494-A | Ligand, complex and application in electrochemical reaction | 南方科技大学 | 2023-04-04 | — | — | CN | disclosed |
| US-11578088-B2 | Organic compound, an electron transport material and an application thereof | XIAMEN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2023-02-14 | — | — | US | disclosed |
| US-20200270280-A1 | ORGANIC COMPOUND, AN ELECTRON TRANSPORT MATERIAL AND AN APPLICATION THEREOF | XIAMEN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2020-08-27 | — | — | US | disclosed |
| CN-107619468-B | Conjugated polymer of ferrocene and phenanthroline derivative and polymerization method and application thereof | 浙江工业大学义乌科学技术研究院有限公司 | 2020-04-07 | — | — | CN | disclosed |
| US-9768390-B2 | Phenanthroline derivative for organic electroluminescent device | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2017-09-19 | — | — | US | disclosed |
| US-9768390-B2 | Phenanthroline derivative for organic electroluminescent device | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2017-09-19 | — | — | US | disclosed |
| US-20100207108-A1 | ELECTRONIC DEVICE INCLUDING PHENANTHROLINE DERIVATIVE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-08-19 | — | — | US | disclosed |
| US-20100207108-A1 | ELECTRONIC DEVICE INCLUDING PHENANTHROLINE DERIVATIVE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-08-19 | — | — | US | disclosed |
| WO-2010075421-A2 | ELECTRONIC DEVICES HAVING LONG LIFETIME | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-01 | — | — | WO | disclosed |
| WO-2010075421-A2 | ELECTRONIC DEVICES HAVING LONG LIFETIME | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-01 | — | — | WO | disclosed |
| WO-2010075411-A2 | PHOTOACTIVE COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-01 | — | — | WO | disclosed |
| WO-2010075411-A2 | PHOTOACTIVE COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-01 | — | — | WO | disclosed |
| WO-2010075379-A2 | ELECTRONIC DEVICE INCLUDING PHENANTHROLINE DERIVATIVE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-01 | — | — | WO | disclosed |
| WO-2010075379-A2 | ELECTRONIC DEVICE INCLUDING PHENANTHROLINE DERIVATIVE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-01 | — | — | WO | disclosed |
| WO-2010068865-A2 | PHOTOACTIVE COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-06-17 | — | — | WO | disclosed |
| WO-2010068865-A2 | PHOTOACTIVE COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11578088-B2 | Organic compound, an electron transport material and an application thereof | OCIAD1, OCIAD2, SLCO4C1 | KDM4E 2749/4885LMNA 2298/4885HSP90AA1 4867/4885 |
| US-20100207108-A1 | ELECTRONIC DEVICE INCLUDING PHENANTHROLINE DERIVATIVE | PAH, AHR, TYR | KDM4E 1156/4885LMNA 2873/4885HSP90AA1 3088/4885 |
| US-20200270280-A1 | ORGANIC COMPOUND, AN ELECTRON TRANSPORT MATERIAL AND AN APPLICATION THEREOF | OCIAD1, OCIAD2, SLCO4C1 | KDM4E 2749/4885LMNA 2298/4885HSP90AA1 4867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.